Stephen Holuk, MD, admitted that he regularly prescribed Schedule II controlled substances for his patients, according to a Dec. 20 news release from the Justice Department.
For four patients, according to the release, Dr. Holuk prescribed opioids in combination with benzodiazepines and muscle relaxers, writing at least 280 prescriptions for opioids for these four patients alone.
He also allegedly prescribed opioids for his patients without consistently conducting functional pain assessments or opioid risk assessments.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.